financetom
Business
financetom
/
Business
/
Correction: AT&T Third-Quarter Sales Dip on Business Wireline Weakness; Telecom Company Reiterates Guidance
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Correction: AT&T Third-Quarter Sales Dip on Business Wireline Weakness; Telecom Company Reiterates Guidance
Oct 23, 2024 9:01 AM

11:41 AM EDT, 10/23/2024 (MT Newswires) -- (Corrects Visible Alpha consensus estimate in fifth paragraph.)

AT&T ( T ) reported an unexpected decline in third-quarter revenue amid challenges in business wireline that led to a multi-billion dollar write-down, though it remains on track to meet its full-year targets.

Revenue dipped to $30.21 billion for the three months ended Sept. 30 from $30.35 billion the year earlier, compared with the $30.45 billion average analyst estimate on Capital IQ. Adjusted earnings per share slid to $0.60 from $0.64 but topped the Street's $0.57 view. The telecommunication giant's shares were up 2.5% in Wednesday trade.

The decline in revenue reflected softer business wireline service performance and lower mobility equipment revenue, which were mostly offset by growth in wireless service and fiber revenues, Chief Financial Officer Pascal Desroches told analysts on a conference call, according to a Capital IQ transcript.

While excluded from adjusted earnings, AT&T ( T ) took a $4.4 billion noncash goodwill impairment charge for its business wireline unit in the third quarter, reflecting "an industry-wide secular decline of legacy services," Desroches said on the call.

Service revenue edged up 0.1% to $25.13 billion while equipment sales fell 3% to $5.08 billion. AT&T's ( T ) postpaid phone net additions fell about 14% year over year to 403,000, compared with the Visible Alpha consensus for a 393,400 reading.

Adjusted earnings before interest, taxes, depreciation and amortization advanced 3.4% in the third quarter, while the company continues to expect the metric to climb in the 3% range for the full year, Desroches told analysts. That's despite a roughly $115 million financial impact related to hurricanes Helene and Milton, with the consumer and business wireline businesses expected to bear most of the impact.

AT&T ( T ) reiterated its full-year adjusted EPS guidance of $2.15 to $2.25, which is in line with the $2.20 Capital IQ consensus. It continues to expect wireless service revenue growth in the 3% range and broadband revenue growth of at least 7%.

Growth in broadband partly reflects fiber momentum, according to Desroches. Third-quarter broadband revenues increased 6.4%, driven by fiber revenue growth of nearly 17%. "We continue to see solid uptake in higher-speed fiber tiers and healthy underlying pricing trends," he said.

Price: 22.24, Change: +0.73, Percent Change: +3.42

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Update: Market Chatter: President Biden to Formally Block Proposed Acquisition of US Steel by Nippon Steel
Update: Market Chatter: President Biden to Formally Block Proposed Acquisition of US Steel by Nippon Steel
Dec 10, 2024
05:36 PM EST, 12/10/2024 (MT Newswires) -- (Adds US comment in fifth and sixth paragraphs.) US Steel (X) slumped Tuesday, closing almost 10% lower, following reports that President Joe Biden plans to formally block the proposed $14.1 billion acquisition of the company by Japan's Nippon Steel, Bloomberg reported Tuesday, citing people familiar with the matter. It's not exactly clear when...
ImmunityBio Plans Public Offering of Common Stock
ImmunityBio Plans Public Offering of Common Stock
Dec 10, 2024
05:32 PM EST, 12/10/2024 (MT Newswires) -- ImmunityBio ( IBRX ) said Tuesday it plans to offer and sell common shares in an underwritten public offering. The company said it expects to give its underwriters, a 30-day option to buy up to an additional 15% of the number of common shares sold in the offering. ImmunityBio ( IBRX ) plans...
Acelyrin Says Uveitis Treatment Trial Fails to Meet Primary Endpoint; Shares Fall After Hours
Acelyrin Says Uveitis Treatment Trial Fails to Meet Primary Endpoint; Shares Fall After Hours
Dec 10, 2024
05:37 PM EST, 12/10/2024 (MT Newswires) -- Acelyrin ( SLRN ) said late Tuesday it will not make any additional internal investment in developing izokibep after a phase 2b/3 trial in treating noninfectious, nonanterior uveitis failed to meet its primary endpoint. Uveitis is a form of eye inflammation. The study didn't meet the primary endpoint of a statistically significant improvement...
Major food companies accused of marketing 'addictive' food to kids
Major food companies accused of marketing 'addictive' food to kids
Dec 10, 2024
Dec 10 (Reuters) - Major food companies, including Kraft Heinz ( KHC ), Mondelez ( MDLZ ) and Coca-Cola, were hit with a new lawsuit in the U.S. on Tuesday accusing them of designing and marketing ultra-processed foods to be addictive to children, causing chronic disease. The lawsuit was filed in the Philadelphia Court of Common Pleas by Bryce Martinez,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved